We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Scientists hail ‘entirely novel approach’ to controlling a disease that kills more than 600,000 a year
Chemify’s technology aims to remove bottleneck of producing molecules in the lab
Prevention strategies close to wiping out transmission in parts of city that were once epicentre of Australia’s Aids epidemic
Efforts by ProMED to raise money from public sector and philanthropists fall short of target
Dementia experts hail ‘watershed moment’ after trial results for donanemab antibody treatment
UK health security agency says low vaccination rates make capital vulnerable to a damaging outbreak
Manipulation of brain signals advancing so fast it threatens human rights, warns UN body
Medicines produced by pharma group will be for domestic use only
A decade ago a large part of Big Pharma gave up on one of humanity’s cruellest diseases. But then a new treatment showed promise
Successful pilot in England will be expanded to more pharma companies and include N Ireland, Scotland and Wales
New treatments have had remarkable results but there are reasons to be cautious
Large-scale study will test GSK’s jab in 26,000 people in Africa and south-east Asia
New research suggests a daytime sleep can delay neurodegeneration, but what about those who just can’t?
Well-prepped countries have fared no better in the past. But there are ways to adapt
Ministers say ‘groupthink’ meant they were persuaded Britain was one of best prepared nations before Covid-19 struck
Former Tory PM admits ‘consequences’ resulted from decision to focus less on other diseases
FDA considers clearing a treatment for Duchenne muscular dystrophy despite lack of ‘unambiguous evidence’ it works
Increasing numbers of younger people in the developed world are being diagnosed with the disease. Scientists are not sure why
Experts are waking up to the threat posed by artificial intelligence programmes if they fall into malevolent hands
Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
Information Commissioner’s Office calls for new regulation to avoid ethical breaches over handling of brain data
Nobel Prize winner who discovered the cause of cervical cancer in humans
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Marketing attractive nicotine products to children risks a whole generation’s health
International Edition